Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Annual report 2019 (pdf):
Abstract (in Norwegian)
Download in single page format - double page (broad) format

Publication overview

Current news and events

The 2020 Oslo University Hospital Researcher Awards to Bretthauer, Hoffmann-Vold and Kristianslund

From left: Hoffmann-Vold, Bretthauer and Kristianslund
From left: Hoffmann-Vold, Bretthauer and Kristianslund

Three Oslo University Hospital scientists have received prestigous awards for their outstanding research. The major prize - the "Excellent Researcher Award" - went to Michael Bretthauer. Anna Hoffmann-Vold and Olav Kristianslund both received the "Early Career Award".

The prize money - 300.000 and 150.000 NOK respectively - is earmarked for research activities. The awards are distributed anually in order to honour excellent scientific work. The awarding process is organized by the hospital's research committee, while an external Scientific Advisory Board has evaluated the candidates. 

PNAS publication:Allows for new treatment of covid-19 patients

From left: Søren Pischke, Tom E. Mollnes and Jan C. Holter
From left: Søren Pischke, Tom E. Mollnes and Jan C. Holter

Researchers from Oslo University Hospital and Vestre Viken show that activation of the innate immune system contributes to breathing difficulties in covid-19 patients. In a study recently published in the prestigious journal "Proceedings of the National Academy of Science" they show that systemic and long-term activation of the complement system occurred in 39 Norwegian covid-19 patients who were hospitalized.

OUH scientists Søren Pischke and Jan Cato Holter are shared first authors, and Tom Erik Mollnes is last author. They have also written a populuar science article about the findings.

Industry development agreement for innovative eye syringe

Morten C. Moe (left) and Jan Teje Andersen
Morten C. Moe (left) and Jan Teje Andersen

The Department of Ophthalmology at Oslo University Hospital and the Laboratory of Adaptive Immunity and Homeostasis of both Oslo University Hospital and University of Oslo, have entered an industry development agreement with the Dutch medical device company SJJ Solutions. The collaboration has resulted in a prototype of a tailor-made syringe optimised for eye injections.

Units and subpages

View all subunitsHide all subunits